Mechanisms involved in the increased sensitivity of the rabbit basilar artery to atrial natriuretic peptide in diabetes

Fecha de publicación:

Autores de IIS La Fe

Grupos

Abstract

Atrial natriuretic peptide (ANP) is a vasodilator with significant regional differences and controversial effects in the cerebral circulation, a vascular bed particularly prone to diabetes-induced complications. The present study has investigated how alloxan-induced diabetes modifies the mechanisms involved in the response of the rabbit basilar artery to ANP. ANP (10(-12) -10(-7) M) relaxed precontracted basilar arteries, with higher potency in diabetic than in control rabbits. In arteries from both groups of animals, endothelium removal reduced ANP-induced relaxations. Inhibition of NO-synthesis attenuated ANP-induced relaxation but this attenuation was lower in diabetic than in control rabbits. In control rabbits, indomethacin displaced to the left the concentration-response curve to ANP, without significantly modifying the E-max value. In diabetic rabbits, indomethacin significantly enhanced arterial relaxations to ANP. In KCl-depolarised arteries, relaxation to ANP was almost abolished both in control and in diabetic rabbits. Iberiotoxin inhibited relaxations to ANP in both groups of rabbits. Glibenclamide and 4-aminopyridine inhibited the ANP-induced relaxations more in diabetic than in control rabbits. Basilar arteries from diabetic rabbits showed decreased natriuretic peptide receptor C expression and no changes in natriuretic peptide receptor A, large conductance calcium-activated K+ channels (BKCa), ATP-sensitive K+ channels (KATP) and voltage-sensitive K+ channels (K-V) expression. These results suggest that diabetes enhances the sensitivity of the rabbit basilar artery to ANP by mechanisms that at least include reduced expression of natriuretic peptide receptor C, and enhanced activity of KATP and KV channels. Furthermore, diabetes reduces endothelial NO and prostacyclin which mediate arterial relaxation to ANP.

Datos de la publicación

ISSN/ISSNe:
0014-2999, 1879-0712

EUROPEAN JOURNAL OF PHARMACOLOGY  ELSEVIER SCIENCE BV

Tipo:
Article
Páginas:
64-72
Factor de Impacto:
1,057 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 4

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Atrial natriuretic peptide; Diabetes; Nitric oxide; Prostanoids; Potassium channels; Rabbit basilar artery

Campos de estudio

Proyectos asociados

INVESTIGACION EN RED DE LAS ENFERMEDADES NEUROLOGICAS

Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA

C03/06 . INSTITUTO DE SALUD CARLOS III . 2003

RED DE INVESTIGACION (RENEVAS)

Investigador Principal: ENRIQUE ALBORCH DOMÍNGUEZ

RD06/0026/0006 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA (FIDIS); FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006

RED DE INNOVACION EN TECNOLOGIAS MEDICAS Y SANITARIAS - RED ITEMAS

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

RD09/0077/00156 . INSTITUTO DE SALUD CARLOS III . 2010

MICROCLUSTERS-CALIDAD, SEGURIDAD Y FUNCIONALIDAD DE ALIMENTOS

Investigador Principal: JOSÉ LUIS MULLOR SANJOSÉ

2011_0171_VLC/CAMPUS_MCI_MULLOR_SALOM . 2011

INFLUENCIA DE LA DIABETES SOBRE LAS VIAS DE SEÑALIZACION DE LOS RECEPTORES ESTROGENICOS CEREBRALES EN EL ICTUS ISQUEMICO AGUDO EXPERIMENTAL: IMPLICACIONES TERAPEUTICAS

Investigador Principal: GERMÁN TORREGROSA BERNABÉ

PI12/00145 . INSTITUTO DE SALUD CARLOS III . 2013

ENFERMEDADES VASCULARES CEREBRALES (ICTUS)

Investigador Principal: JUAN BAUTISTA SALOM SANVALERO

RD12/0014/0004 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013

EFECTO DE UN HIDROLIZADO DE LACTOFERRINA BOVINA SOBRE LA PRESIÓN ARTERIAL EN SUJETOS PREHIPERTENSOS Y LEVEMENTE HIPERTENSOS NO MEDICADOS. / EFFECT OF A BOVINE LACTOFERRIN HYDROLYSATE ON BLOOD PRESSURE IN PREHYPERTENSIVE AND MILDLY HYPERTENSIVE NON-MEDICATED SUBJECTS.

2014_0385_CRC_SALOM . 2014

NANOMATERIALES INTELIGENTES, SONDAS Y DISPOSITIVOS PARA EL DESARROLLO INTEGRADO DE NUEVAS HERRAMIENTAS APLICADAS AL CAMPO BIOMÉDICO

Investigador Principal: JUAN BAUTISTA SALOM SANVALERO

MAT2015-64139-C4-1-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016

RED DE ENFERMEDADES VASCULARES CEREBRALES. INVICTUS PLUS.

Investigador Principal: JUAN BAUTISTA SALOM SANVALERO

RD16/0019/0008 . INSTITUTO DE SALUD CARLOS III . 2017

SMARRTS-II- MARCADORES DE ANGIOGENESIS Y REPARACIÓN DURANTE TERAPIA REHABILITADORA TRAS EL ICTUS: ESTUDIO CLÍNICO MULTICÉNTRICO.

Investigador Principal: ANNA ROSELL NOVEL

PI16/00981 . 2016

ESTUDIO DE DABIGATRÁN EN LA FASE TEMPRANA DEL ICTUS. ESTUDIO DE NUEVOS MARCADORES DE NEUROIMAGEN Y DE BIOMARCADORES. (ESTUDIO SEDMAN)

Investigador Principal: AIDA LAGO MARTÍN

JKB-DAB-2016-01 . 2018

Cita

Compartir